JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Radiowave ablation and mucopexy for prolapsing hemorrhoids--a pilot study.

OBJECTIVE: The author proposes a technique of radiowave ablation and mucopexy of hemorrhoids for patients having symptomatic and prolapsing hemorrhoids and enumerates the events in such patients over 10 years.

MATERIAL AND METHOD: From May 1997 through December 2007, 3148 patients were included in the study. The hemorrhoids were ablated using radiowaves through a Ellman radiowave generator and were followed by suture ligation with absorbable suture material under vision. Operating time, postoperative complications, time to return to work, and outcome of the procedure were analyzed.

RESULTS: The mean procedure time was 8+/-0 min (range, 5-14 min). The mean total analgesic dose and duration of pain control using analgesics was 17+/-5 tablets, and 10+/-4 days respectively. The mean period of incapacity for work was 6 days [range 4-17 days]. Complications were identified in 4.8% patients. The postoperative follow-up after 4 weeks revealed therapeutic success in 3013 patients (95.7%), who presented with hemorrhoidal bleeding. Prolapse was no longer observed in 3085 (98%) of patients and 3022 (96%) patients experienced no pain after defecation. Up to December 2006, a total of 2897 patients were treated with this method. 2246 patients responded to our inquiry conducted at the beginning of 2008. Ninety-six percent of these patients confirmed that they no longer experienced any bleeding or pain during defecation and ninety-two percent patients did not had any prolapse.

CONCLUSIONS: This study shows that radiowave ablation followed by suture ligation of hemorrhoids is a simple, cost effective and convenient modality in treating prolapsing hemorrhoids.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app